MD1 Stock Chart & Stats
€23.30
-€0.40(-1.95%)
At close: 4:00 PM EDT
€23.30
-€0.40(-1.95%)
Day’s Range― - ―
52-Week Range€16.30 - €24.40
Previous CloseN/A
Volume0.00
Average Volume (3M)96.00
Market Cap
€415.90M
Enterprise Value€4.14K
Total Cash (Recent Filing)€183.45M
Total Debt (Recent Filing)€26.17M
Price to Earnings (P/E)27.2
Beta0.53
Next Earnings
Oct 23, 2026EPS Estimate
0.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.71
Shares Outstanding18,337,336
10 Day Avg. Volume0
30 Day Avg. Volume96
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medistim ASA News
MD1 FAQ
What was Medistim ASA’s price range in the past 12 months?
Medistim ASA lowest stock price was €16.30 and its highest was €24.40 in the past 12 months.
What is Medistim ASA’s market cap?
Medistim ASA’s market cap is €415.90M.
When is Medistim ASA’s upcoming earnings report date?
Medistim ASA’s upcoming earnings report date is Oct 23, 2026 which is in 39 days.
How were Medistim ASA’s earnings last quarter?
Medistim ASA released its earnings results on Aug 21, 2026. The company reported €0.245 earnings per share for the quarter, beating the consensus estimate of €0.205 by €0.041.
Is Medistim ASA overvalued?
According to Wall Street analysts Medistim ASA’s price is currently Overvalued.
Does Medistim ASA pay dividends?
Medistim ASA does not currently pay dividends.
What is Medistim ASA’s EPS estimate?
Medistim ASA’s EPS estimate is 0.2.
How many shares outstanding does Medistim ASA have?
Medistim ASA has 18,337,336 shares outstanding.
What happened to Medistim ASA’s price movement after its last earnings report?
Medistim ASA reported an EPS of €0.245 in its last earnings report, beating expectations of €0.205. Following the earnings report the stock price went up 3.241%.
Which hedge fund is a major shareholder of Medistim ASA?
Currently, no hedge funds are holding shares in DE:MD1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.